New data support use of Exalenz Bioscience's BreathID test for diagnosing H. pylori infection

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced new published data supporting the use of the Company's point-of-care BreathID urea breath test for diagnosing Helicobacter pylori infection (H. pylori) in the emergency department (ED) setting.



from The Medical News http://www.news-medical.net/news/20150413/New-data-support-use-of-Exalenz-Biosciences-BreathID-test-for-diagnosing-H-pylori-infection.aspx